Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan:146:110356.
doi: 10.1016/j.mehy.2020.110356. Epub 2020 Nov 17.

Development of integrated microfluidic platform coupled with Surface-enhanced Raman Spectroscopy for diagnosis of COVID-19

Siddhita A Jadhav  1 , Pullithadathil Biji  2 , Manoj Kumar Panthalingal  3 , C Murali Krishna  4 , S Rajkumar  5 , Dattatraya S Joshi  5 , Natarajan Sundaram  5
Affiliations

Development of integrated microfluidic platform coupled with Surface-enhanced Raman Spectroscopy for diagnosis of COVID-19

Siddhita A Jadhav et al. Med Hypotheses. 2021 Jan.

Abstract

Corona Virus Disease 19 (COVID-19) pandemic has created an alarming situation across the globe. Varieties of diagnostic protocols are being developed for the diagnosis of COVID-19. Many of these diagnostic protocols however, have limitations such as for example unacceptable no of false-positive and false-negative cases, particularly during the early stages of infection. At present, the real-time (quantitative) reverse transcriptase-polymerase chain reaction (RT-PCR) is considered the gold standard for COVID-19 diagnosis. However, RT-PCR based tests are complex, expensive, time consuming and involve pre-processing of samples. A swift, sensitive, inexpensive protocol for mass screening is urgently needed to contain this pandemic. There is urgent need to harness new powerful technologies for accurate detection not only of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) but also combating the emergence of pandemics of new viruses as well. To overcome the current challenges, the authors propose a diagnostic protocol based on Surface-enhanced Raman Spectroscopy (SERS) coupled with microfluidic devices containing integrated microchannels functionalized either with vertically aligned Au/Ag coated carbon nanotubes or with disposable electrospun micro/nano-filter membranes. These devices have the potential to successfully trap viruses from diverse biological fluids/secretions including saliva, nasopharyngeal, tear etc. These can thus enrich the viral titre and enable accurate identification of the viruses from their respective Raman signatures. If the device is successfully developed and proven to detect target viruses, it would facilitate rapid screening of symptomatic as well as asymptomatic individuals of COVID-19. This would be a valuable diagnostic tool not only for mass screening of current COVID-19 pandemic but also in viral pandemic outbreaks of future.

Keywords: Microfluidic Platforms; Raman Spectroscopy; SARS-CoV-2.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Proposed microfluidic platform for virus detection.
Fig. 2
Fig. 2
Proposed VACNTs functionalized microfluidic platform.
See this image and copyright information in PMC

References

    1. Mousavizadeh L., Ghasemi S. Genotype and phenotype of COVID-19: Their roles in pathogenesis. J Microbiol Immunol Infect. 2020 Available from: http://www.sciencedirect.com/science/article/pii/S1684118220300827. - PMC - PubMed
    1. Kannan S, Ali PSS, Sheeza A, Hemalatha K. COVID-19 (Novel Coronavirus) - Recent trends. Eur Rev Med Pharmacol Sci. 2020;24:2006–11. - PubMed
    1. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a C. - PMC - PubMed
    1. Carter L.J., Garner L.V., Smoot J.W., Li Y., Zhou Q., Saveson C.J. Assay techniques and test development for COVID-19 diagnosis. ACS Cent Sci [Internet] 2020;6(5):591–605. Available from: https://doi.org/10.1021/acscentsci.0c00501. - PMC - PubMed
    1. Moore T.J., Moody A.S., Payne T.D., Sarabia G.M., Daniel A.R., Sharma B. In vitro and in vivo SERS biosensing for disease diagnosis. Biosensors. 2018;8(2) - PMC - PubMed